Vera Luxner | Director of Advocacy Relations
Rare Disease Advisor
Hello,
I am honored to serve the rare disease community as the Director of Advocacy Relations for Rare Disease Advisor (Haymarket Media US)—a role specifically created to bridge critical gaps among patients, healthcare professionals, scientists, government agencies, and industry. The creation of this role reflects RDA's deep commitment to amplifying patient voices, advancing education (including through myCME), fostering innovative partnerships, and driving urgent action to shorten time to diagnosis and save lives.
I will be speaking at WODC about patient advocacy, alongside our patient-columnists, on translating lived experience into regulatory advances. Please join us and also connect with me to participate in a short, complimentary spotlight interview that reaches our subscribers.
Please feel free to reach out if you would like to schedule a time to meet up.
Kind regards,
Vera Luxner
301-520-1050
Appearances:
Day 2 - World Orphan Drug Congress USA 2026 @ 14:00
Beyond Awareness: Translating Lived Experience into Regulatory Evidence
The rare disease ecosystem is undergoing a strategic shift from general awareness to actionable
advocacy. While patient voices are increasingly invited into drug development, regulators and HTA
bodies still struggle to translate lived experience into recognized evidence.
This panel examines how specialized rare disease media—specifically Rare Disease
Advisor—transforms patient narratives into actionable “human data.” Through curated patient
columns, RDA creates a validated, public record of patient-reported outcomes that informs endpoint
development, supports PFDD initiatives, and shortens the diagnostic odyssey. Panelists will explore
how media can serve as a strategic partner in clinical development, regulatory decision-making, and
early disease recognition.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events